New Findings from Study Directed by Georgia CTSA CPTR Graduate Offer Potential Breakthrough in HIV Cure Research
The study led by Monica Reece, PhD candidate in Emory’s Microbiology and Genetics Program, and directed by Christina Gavegnano, PhD, Gavegnano Drug Discovery Program, Georgia CTSA Certificate Program in Translational Research (CPTR) graduate, demonstrates the potential of Jak inhibitors, specifically ruxolitinib, to significantly decay the viral reservoir in people with HIV, offering a novel pathway toward long-term remission or a cure.